Mai Capital Management Codexis, Inc. Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
A detailed history of Mai Capital Management transactions in Codexis, Inc. stock. As of the latest transaction made, Mai Capital Management holds 138 shares of CDXS stock, worth $605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138Holding current value
$605% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CDXS
# of Institutions
143Shares Held
60.6MCall Options Held
68.5KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.84MShares$38.8 Million8.29% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$35.6 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$29.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$19.6 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$13.2 Million1.53% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $288M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...